Document is current
Any future updates will be listed below
-
Authors
Iannone, Luigi Francesco
Fattori, Davide
Geppetti, Pierangelo
De Cesaris, Francesco
- License Information
-
More Information
Article History
Received: 24 May 2021
Accepted: 18 September 2021
First Online: 29 September 2021
Declarations
:
: All patients have been previously included in the Italian Registry of Headache (<i>Registro Italiano delle Cefalee, RICe</i>), signing an informed consent which included the option to perform headache-related sub-studies. The protocol was reviewed and approved by the Ethical Committee of the University of Florence ‘Studio RICe, 14591_oss’.
: P.G.: received personal fees from Allergan, Eli Lilly, Novartis, Amgen, TEVA; Grants from Amgen, TEVA, Eli-Lilly, Allergan, Chiesi; Scientific Advisory Board, Endosome Therapeutics; Founding scientist of FloNext srl, Spinoff of the University of Florence. F.D.C. received personal fees from TEVA, Eli Lilly, Novartis. Other authors have no conflicting interests.
